Introduction
Changes in mitochondrial function are thought to be involved in apoptois induction. In staurosporineinduced apoptosis, cytochrome c is released from mitochondria which leads to the activation of caspase 3 (Li et al., 1997; Liu et al., 1996) . It is very likely that cytochrome c release from mitochondria can induce apoptosis, however several other reports imply dierent roles of cytochrome c in apoptosis signaling (Adachi et al., 1997; Tang et al., 1998) . In dexamethasone-induced apoptosis, MPT is induced Zamzami et al., 1995) and the apoptosis-inducing protein apoptogeneic protease is released from mitochondria.
Several reagents can open mitochondrial permeability transition pores, leading to a release of apoptogeneic protease and caspase 3 activation (Susin et al., 1997) .
Inducers of MPT can release cytochrome c from mitochondria (Yang and Cortopassi, 1998) . However, the induction of MPT is not always necessary for the release of cytochrome c (Yang et al., 1997) . Several reports have shown that reactive oxygen species (ROS), phospholipases, and Ca
2+
ions can promote the induction of MPT (Skulachev, 1996) ; however, the link between the stimulus of MPT inducing reagents and the induction of MPT is not clear. Overexpression of bcl-2 abrogated TNF-induced apoptosis, increased mitochondrial membrane potential , and inhibited cytochrome c release (Kluck et al., 1997; Yang et al., 1997) . This suggests that these events are closely related during apoptosis. However, the relationship between MPT induction and cytochrome c release in TNF-induced apoptosis has not yet been elucidated.
Involvement of mitochondria has been implicated in TNF-induced cell death. During the early stage of cell death induced by TNF, mitochondria swell (Rutka et al., 1988) and mitochondrial respiration chains (MRC) are inhibited (Higuchi et al., 1992; Schulze-Ostho et al., 1992) . Because mitochondria are the source of ATP, inhibition of MRC will ultimately decrease cellular ATP levels leading to cell death. Additional mechanisms may be involved in TNF-induced cytotoxicity. Since mitochondria are the main source of ROS, which have been implicated in both apoptosis and necrosis (Lennon et al., 1991) , mitochondriaderived ROS may provide a link between mitochondria and cell death. This hypothesis is also supported by the observation that under low oxygen conditions, TNF-induced cytotoxicity was reduced (Matthews et al., 1987) . Furthermore, manganese superoxide dismutase (Mn SOD), located in mitochondria, dismutates mitochondrial superoxide anion, which has leaked from the electron transport chain, and abrogates TNFmediated apoptosis (Wong et al., 1989; Wong and Goeddel, 1988) . In contrast, Zn/Cu SOD, which is located in the cytosol, does not inhibit TNF-induced apoptosis. Furthermore, TNF increased hydrogen peroxide generation in the mitochondria in certain systems (Hennet et al., 1993) and inhibited MRC through antioxidant-sensitive pathway (Higuchi et al., 1992) . These results indicate that superoxide anion from MRC is involved in TNF-induced cell death.
It is likely that respiratory function may aect oxidative stress. In a previous study to investigate the requirements of mitochondrial respiratory function in TNF-induced apoptosis signaling, we generated a panel of respiration de®cient clones and their reconstituted cybrids with normal mitochondria (Higuchi et al., 1997) . We showed that mitochondrial respiratory activity correlated with the ability of TNF, anti-Fas antibody, and serum starvation, but not staurosporine, to induce apoptosis. Our study placed mitochondrial respiratory function at a step prior to the activation of a caspase 3-like protease in TNF-induced apoptosis signaling. Therefore, it is very likely that TNF aects mitochrondrial respiratory function and then activates caspase 3 through a respiratory function dependent fashion. However, changes in mitochondrial respiratory function by TNF-induced apoptosis have not been elucidated.
Mitochondrial respiratory chain is composed of ®ve enzyme complexes: NADH:ubiquinone oxidoreductase (complex I), succinate:ubiquinone oxidoreductase (complex II), ubiquinone:ferricytochrome c oxidoreductase (complex III), ferrocytochrome c: oxygen oxidoreductase (complex IV), and F0F1-ATPase (complex V). As shown in Figure 1 , complexes I, II, III and IV plus coenzyme Q and cytochrome c make up MRC and complex V generates ATP by coupling with the proton energy generated at complex I, III and IV. Several reports imply that the damage to complexes I and III can induce apoptosis (Guidarelli et al., 1996; Hartley et al., 1994) and that complex V might be involved in apoptosis (Matsuyama et al., 1998) .
In this paper, we investigated the role of MRC during an early step of apoptotic signaling. We demonstrated that the inhibition of MRC complex I occurs during the early stages of mitochondrial changes in apoptosis. We also showed that inhibition of MRC complex I released cytochrome c from mitochondria and induced MPT. Furthermore, we investigated the involvement of an antioxidant-sensitive pathway and caspases in cytochrome c release and MPT induction by complex I inhibition leading to apoptosis.
Results

Inhibition of MRC complex I by TNF and serum starvation
We have shown previously that mitochondrial respiratory function is involved in the induction of apoptosis by TNF, anti-Fas, and serum starvation (Higuchi et al., 1997) . Inhibition of certain components of MRC can aect electron¯ow and regulate apoptotic response. Figure 1 shows the MRC complexes involved in the mitochondrial electron transfer system. Initially, we investigated the eect of TNF on MRC complexes in ML-1a cells. A 90 min treatment of ML-1a cells with TNF plus protein synthesis inhibitor cycloheximide induced apoptosis (Higuchi et al., 1995) . Cells were treated with TNF and cycloheximide for the times indicated in Figure 2 and then tested for their eect on MRC activity. A 10 min treatment of ML-1a cells with TNF abrogated 25% of the malate/ glutamate-dependent oxygen consumption, which measures electron¯ow through complexes I, III and IV (see Figure 1 ), whereas the same treatment showed no eect on succinate-dependent oxygen consumption, which measures electron¯ow through complexes II, III and IV (Figure 2) . A 20 min treatment inhibited 84% of malate/glutamate-dependent oxygen consumption and 41% of succinate-dependent consumption ( Figure  2 ). These results indicate that MRC complex I was inhibited prior to the inhibition of complexes II, III and IV.
We also investigated whether the speci®c inhibition of MRC complex I could be observed in apoptosis 7 ML-1a cells were incubated with 1 nM TNF for the indicated times and then the rates of O 2 uptake was measured as described under Materials and methods. The concentrations of substrates were 5 mM malate and 5 mM succinate respectively induced by serum starvation. ML-1a cells were apoptotic 48 h after serum starvation (Higuchi et al., 1997) . Twenty-four hours after serum starvation, 95% of electron¯ow through MRC complexes I, III and IV was inhibited (Table 1 ). In comparison, 49% of electron¯ow through MRC complexes II, III and IV, and 19% of electron¯ow through MRC complexes III and IV was inhibited (Table 1) . These results indicate that complex I is the most signi®cantly inhibited MRC component during apoptotic conditions induced by serum starvation.
Induction of apoptosis by the inhibition of MRC complex I
To investigate whether apoptosis could be induced by the inhibition of MRC, the eect of MRC inhibitors in the presence of cycloheximide was tested. Rotenone, an inhibitor of MRC complex I, induced apoptosis. However we were unable to observe induction of apoptosis by TTFA (inhibitor of MRC complex II), antimycin A (inhibitor of MRC complex III), or sodium azide (inhibitor of MRC complex IV) ( Figure 3a ). The majority of speci®c oxygen consumption was blocked by 2 mM rotenone, 100 mM TTFA, 2 mg/ml antimycin A, or 100 mM sodium azide respectively. Similar to TNF, apoptosis induced by rotenone was greatly increased in the presence of protein synthesis inhibitor cycloheximide (Figure 3b ). Similar morphological changes associated with TNFinduced apoptosis including nuclear condensation and blebbing ( Figure 4 ) and formation of membrane blebbing and apoptotic bodies (data not shown) were also observed by rotenone. To determine if rotenone acted speci®cally on mitochondrial respiratory function, its eect on ML-1a cells and its respiration de®cient and re-constituted clones was examined. Rotenone induced apoptosis in ML-1a cells but not in respiration-de®cient clone 19, furthermore, rotenone-induced apoptosis reappeared in the cybrid clones ( 4610 4 ) were incubated with 10 mM rotenone in the presence or absence of 1 mg/ml cycloheximide for 90 min, and fragmented DNA was determined as described under Materials and methods
Involvement of electron transfer regulated by complex I inhibition in apoptosis
Inhibition of MRC complex I may increase electron ow through complexes II, III and IV to compensate for the decrease in ATP synthesis (Figure 1 ). Such an increase might be inhibited by TTFA, an inhibitor of complex II. TTFA nearly completely inhibited both TNF-induced apoptosis and rotenone-induced apoptosis (Table 2) , supporting the idea that a change in electron¯ow through complexes II, III and IV could cause apoptosis.
Several reports have shown the involvement of mitochondrial ROS in TNF-induced apoptosis. An increase in electron¯ow upregulates the generation of ROS from MRC (Ksenzenko et al., 1983; Turrens and Boveris, 1980) . To investigate whether oxidative stress is involved at a step subsequent to complex I inhibition, the eect of antioxidant PDTC on TNFand rotenone-induced apoptosis was tested. PDTC nearly completely inhibited the apoptotic eect of TNF and that of rotenone (Table 2) , suggesting the involvement of an antioxidant-sensitive pathway following complex I inhibition in apoptotic signaling.
Recently, several reports suggest the involvement of mitochondrial membrane potential (Shimizu et al., 1998) and F0F1-ATPase (complex V) (Matsuyama et al., 1998 ) on apoptosis. We tested whether the uncoupler FCCP and oligomycin A, an inhibitor of F0F1-ATPase, could inhibit TNF-and rotenoneinduced apoptosis. As shown in Table 2 , both of the inhibitors inhibited TNF and rotenone-induced apoptosis. These results indicate that mitochondrial membrane potential and complex V might be involved in apoptosis signaling subsequent to complex I inhibition.
Induction of MPT and cytochrome c release by the inhibition of complex I
Release of cytochrome c from mitochondria and induction of MPT were considered to be the causes of apoptosis. We tested whether TNF and rotenone in the presence of cycloheximide could induce these changes. Figure 6 shows that cytochrome c was released when ML-1a cells were treated with TNF or rotenone in the presence of cycloheximide, whereas TNF, rotenone, and cycloheximide alone had no eect. Induction of MPT was estimated by detecting mitochrondrial membrane potential . Induction of MPT was only observed when cells were stimulated by TNF or rotenone in the presence of cycloheximide (Figure 7) . TNF, rotenone, or cycloheximide alone were ineective at least within 90 min treatment. These results indicate that inhibition of MRC complex I could cause the release of cytochrome c and induction of MPT.
If cytochrome c release and MPT induction in TNFinduced apoptosis were the result of MRC complex I inhibition, TNF may induce complex I inhibition which would then lead to cytochrome c release and MPT induction. We investigated these time-dependent mitochondrial changes. Figure 8 shows that complex I inhibition was ®rst observed, then cytochrome c was released and MPT was induced.
Next, we examined whether a caspase 3-like protease and antioxidant-sensitive pathway were involved in the signal sequences between complex I inhibition and the induction of MPT or cytochrome c release. To investigate the role of caspase 3-like protease and ROS, a caspase 3 inhibitor, z-DEVD-CH 2 F, and antioxidant pyrrolidine dithiocarbamate (PDTC) were used respectively. z-DEVD-CH 2 F and PDTC nearly completely inhibited TNF-and rotenone-induced apoptosis in ML-1a cells (Table 2) . ML-1a cells were treated with TNF and rotenone in the presence of cycloheximide, and the eect of z-DEVD-CH 2 F and PDTC on the induction of cytochrome c release and Figure 4 Induction of apoptosis by TNF and rotenone. ML-1a cells were incubated with or without 1 nM TNF or 10 mM rotenone in the presence or absence of 1 mg/ml cycloheximide, stained by propidium iodide and Hoechst 33432 and investigated visually by¯uorescent microscopy as described under Materials and methods H-TdR prelabeled (DNA fragmentation) and nonlabeled (capase 3-like protease) ML-1a, clone 19, and reconstituted clones p1, p2, and p3 were incubated with 10 mM rotenone for 90 min and tested for DNA fragmentation and capase 3-like protease activity as described under Materials and methods ) were incubated with 1 nM TNF or 10 mM rotenone plus 1 mg/ml cyclohexidimide in the absence or presence of TTFA (1 mM), FCCP (2.5 mM), oligomycin A (5 mM), PDTC (50 mM), and z-DEVD-CH 2 F (50 mM) for 90 min, and fragmented DNA was determined as described under Materials and methods Figure 6 Cytochrome c release from mitochondria by TNF and rotenone. ML-1a cells were incubated with or without TNF or rotenone in the presence or absence of cycloheximide for 90 min. After the cytosolic fraction was obtained, cytochrome c release from mitochondria was detected by Western blotting using anticytochrome c antibody as described under Materials and methods
Figure 7
Induction of MPT by TNF and rotenone. ML-1a cells were incubated for 90 min in the presence or absence of TNF or rotenone with or without cycloheximide and induction of MPT was detected by FACS analysis by using 3,3'-dehexyloxacarbocarnine iodine (DiOC 6 ) as a probe as described under Materials and methods the induction of MPT was investigated. As shown in Figure 9 , rotenone-and TNF-induced cytochrome c release was inhibited by PDTC but not by z-DEVD-CH 2 F, suggesting that an antioxidant-sensitive pathway but not caspase 3-like proteases is involved in the signal sequences prior to cytochrome c release. Figure  10 shows that MPT induction could be inhibited by both z-DEVD-CH 2 F and PDTC, suggesting that caspase 3-like protease and an antioxidant-sensitive pathway are involved prior to the induction of MPT.
In summary, TNF-induced MRC complex I inhibition induces cytochrome c release through an antioxidant-sensitive pathway and MPT through an antioxidant-sensitive and caspase dependent way.
Discussion
In this report, we investigated the eect of TNF on MRC complexes and their role in apoptosis signaling. To study the eect of TNF on MRC, we showed that mitochondrial respiratory chain complex I can be inhibited prior to the other changes tested, such as the inhibition of MRC complexes II, III and IV, MPT induction, and cytochrome c release. Rotenone, an inhibitor of MRC complex I but not the other complexes, induced apoptosis in ML-1a cells but not in respiration de®cient cells. These results clearly indicate that TNF induces MRC complex I inhibition and that it is the cause of the induction of apoptosis in TNF-induced apoptosis signaling. Furthermore, we also showed that complex I inhibition can cause cytochrome c release through an antioxidant-sensitive rather than a caspase-dependent fashion, whereas MPT induction by complex I inhibition requires both of the antioxidant-sensitive and caspase-dependent signals.
We and others reported that MRC is inhibited in the early stage of necrotic cell death induced by TNF in L.P3 cells, a clone of L929, and in L-929 cells (Higuchi et al., 1992; Schulze-Ostho et al., 1992) . We also showed that this step of MRC inhibition is blocked in TNF resistant cells, and is needed to induce the late event of cell death, which includes activation of PLA 2 . The role of mitochondria in TNF-induced necrosis may be explained by one of the following two mechanisms: (1) Damage to MRC will decrease cellular ATP level, and in turn induce necrosis; (2) Damage to MRC releases Ca
2+
. The latter mechanism can also induce apoptosis (Richter, 1993) .
Induction of apoptosis by complex I inhibitors such as rotenone and 1-methyl-4-phenylpyridinium (Hartley et al., 1994) has been reported. In such apoptotic reactions, apoptosis does not always result from a decrease in cellular ATP level (Pastorino et al., 1995) , nor from an increase in Ca 2+ (Gabai et al., 1992) , which are generally considered to be induced by MRC inhibitors. Oxidative energy is generated by F0F1-ATPase via coupled vectorial electron translocation at three stages along the respiratory chain, represented by complexes I, III and IV (Figure 1 ). When MRC complex I is inhibited, the succinate concentration might increase in the TCA cycle and electron¯ow through complexes II, III and IV might increase to compensate for the decrease in ATP synthesis through complexes I, III and IV. TTFA, an inhibitor of complex II, strongly inhibited TNF-and rotenoneinduced apoptosis, supporting the idea that the change in the metabolism through complexes II, III and IV is the cause of apoptosis induction. Anti-oxidant PDTC inhibited TNF-and rotenone-induced apoptosis ( Table  2 ), suggesting that an antioxidant-sensitive pathway is involved in apoptosis. The change in electron transfer Figure 8 Time dependent induction of complex I inhibition, cytochrome c release, and MPT. ML-1a cells were incubated with TNF or rotenone in the presence of 1 mg/ml cycloheximide for indicated times, and complex I inhibition, cytochrome c release, and MPT induction was detected as described under Materials and methods Figure 9 The eect of z-DEVD-CH 2 F and PDTC on TNF-and rotenone-induced cytochrome c release. ML-1a cells were incubated for 90 min in the presence or absence of TNF or rotenone plus cycloheximide with and without 25 mM z-DEVD-CH2F or 25 mM PDTC and the release of cytochrome c from mitochondria was detected as described under Materials and methods in MRC might regulate this antioxidant-sensitive pathway by one of the following ways: (1) Reduced MRC might generate more ROS; (2) Inhibition of oxygen consumption in MRC increases oxygen concentration in mitochondria and in turn increases ROS generation; (3) A change in electron transfer may aect oxidation/reduction control in mitochondria and cytosols which may regulate apoptosis. In the last case the generation of ROS is not always necessary. An increase in ROS was also observed in septic shock (Taylor et al., 1995) . Recently, the role of F0F1-ATPase in apoptosis has been suggested (Matsuyama et al., 1998) . F0F1-ATPase generates ATP by coupling with the electron transport chain, and this coupling is essential to generate ROS from MRC (Skulachev, 1996) . Taken together, MRC complex I inhibition may induce apoptosis through an antioxidant-sensitive pathway by coupling with F0F1-ATPase. However, induction of apoptosis by ROS alone required a longer incubation time than that with TNF (data not shown); ROS generation alone may not completely explain the rapid induction of apoptosis by TNF.
Complex III inhibitor antimycin A has been known to induce apoptosis. In our system, antimycin A alone could not induce apoptosis up to 90 min but could induce apoptosis 180 min after treatment (Higuchi unpublished results) . We also observed that cyclohex- Figure 10 Inhibition of TNF-and rotenone-induced MPT by z-DEVD-CH 2 F and PDTC. ML-1a cells were incubated for 90 min in the presence or absence of TNF or rotenone plus cycloheximide with and without 25 mM z-DEVD-CH2F or 25 mM PDTC and induction of MPT was detected by FACS analysis by using 3,3'-dehexyloxacarbocarnine iodine (DiOC 6 ) as a probe as described under Materials and methods Figure 11 Mechanistic scheme of TNF-induced apoptosis signaling imide had no eect on antimycin A-induced apoptosis (Higuchi unpublished results) . Possibly, dierent mechanisms are involved in each apoptosis induction and further investigation is now underway.
In addition to TNF, rotenone induced cytochrome c release from mitochondria and MPT, indicating that complex I inhibition could be the cause of these mitochondrial changes. MPT induction is estimated by the decrease in DiOC 6 which detects mitochondrial membrane potential. Since we did not have a direct method to detect MPT induction in intact cells, we utilized this method. Therefore, although several reports indicate the induction of MPT by TNF (Pastorino et al., 1996) , we cannot distinguish MPT induction and the decrease in mitochondrial membrane potential, which is recently considered to be important for apoptosis signalings (Shimizu et al., 1998) . Since PDTC can inhibit rotenone-induced apoptosis, cytochrome c release, and MPT induction, an antioxidantsensitive pathway might be involved between complex I inhibition and cytochrome c release or MPT induction in TNF signalings. In addition, caspase 3 inhibitor z-DEVD-CH 2 F inhibited rotenone-induced MPT induction but not cytochrome c release. Involvement of a caspase 3-like protease in MPT induction was supported by other investigators (Marzo et al., 1998) . These results indicate that caspase 3-like protease is involved between complex I and MPT induction and subsequent to cytochrome c release. However, it is still possible that caspases which cannot be inhibited by z-DEVD-CH 2 F, such as caspase 1-like protease, may work prior to cytochrome c release. From these results, we derived the mechanistic scheme in Figure 11 . TNF treatment inhibits MRC complex I, which then induces the release of cytochrome c through a PDTC-sensitive fashion (possibly by ROS). Cytochrome c release may activate caspase 3-like protease to induce MPT and apoptosis. We demonstrated that inhibition of MRC complex I is an mitochondrial event prior to cytochrome c release and MPT induction and that MRC complex I inhibition is the cause of the release of cytochrome c and MPT induction. The order of apoptotic signalings of cytochrome c ± caspase activation ± MPT induction was also observed in UV irradiation-or staurosporine-induced apoptosis (BossyWetzel et al., 1998) . In conclusion, complex I inhibition is considered to be an important turning point of apoptotic signaling. Although an inducer of MPT can induce apoptosis , we are not sure whether MPT induction is responsible for the signal sequences between cytochrome c release and apoptosis, since it is still possible that MPT induction downstream of caspase 3 activation can further activate caspase and increase apoptosis signaling. In addition, the possibility of cytochrome c independent mechanisms (Tang et al., 1998) after complex I inhibition still remains.
Complex I inhibition aected electron transfer through complex II, III and IV, and may release cytochrome c possibly through antioxidant-sensitive fashion. Cytochrome c is located on the mitochondrial inner membrane. Cytochrome c can be released by the disruption of outer membrane (Reed, 1997) or through certain transport. If the latter is the case, the dissociation of cytochrome c from mitochondrial inner membrane is also necessary to release cytochrome c from mitochondria. Association of cytochrome c to mitochondrial inner membrane is dependent on its interaction with acidic lipid cardiolipin and their association is downregulated by ROS (Soussi et al., 1990) . It is possible that an antioxidant-sensitive mechanism induced by complex I inhibition can dissociate cytochrome c from mitochondrial inner membrane. Possibly, both of these mechanisms, either dependently or independently, work to release cytochrome c from mitochondria leading to apoptosis.
How complex I is inhibited after TNF treatment has not been elucidated. Interestingly, Bcl-2 can inhibit complex I damage by a Ca 2+ overload and an increase in Ca 2+ uptake capacity when the electron is transferred through complexes I, III and IV (Murphy et al., 1996) . Therefore, it is very possible that Bcl-2 can regulate the activity of MRC complex I through unknown mechanisms, and thus regulate apoptosis. Further analysis is necessary to elucidate the exact mechanisms.
Materials and methods
Materials
Gentamicin, RPMI-1640 medium, and fetal calf serum (FCS) were obtained from GIBCO (Grand Island, NY, USA). Ethidium bromide, uridine, glucose, pyruvate, dimethyl sulfoxide, sucrose, EGTA, adenine diphosphate (ADP) okadaic acid, H-7, rotenone, theonyltri¯uoro-acetone (TTFA), antimycin A, sodium azide, oligomycin A, carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) malate, glutamate, succinate, ascorbate, N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) and pyrrolidine dithiocarbamate were obtained from Sigma Chemical Co. (St. Louis, MO, USA).
Cell lines
Myelogenous leukemia ML-1a were obtained from Dr Ken Takeda (Showa University, Tokyo, Japan). All cell lines, except clone 19, were grown in RPMI-1640 medium supplemented with 10% FCS and gentamicin (50 mg/ml) (essential medium). Respiration de®cient clone 19 was grown in RPMI-1640 medium with 10% FCS and gentamicin (50 mg/ml) supplemented with 4.5 mg/ml glucose, 5 mg/ml uridine, and 100 mg/ml pyruvate (enriched medium). The cells were seeded at a density of 1610 5 cells/ml in T-25¯asks (Falcon 3013, Becton Dickinson Labware, Lincoln Park, NJ, USA) containing 10 ml of essential medium and grown at 378C in an atmosphere of 95% air and 5% CO 2 . Cell cultures were split every 3 to 5 days.
Establishment of respiration de®cient and reconstituted clones
The methods to establish respiration de®cient clone 19 and reconstituted clones p1, p2, and p3 are shown elsewhere (Higuchi et al., 1997) .
DNA fragmentation assay
DNA fragmentation induced by TNF was assayed by the modi®ed method as described (Higuchi et al., 1995) . Brie¯y, ML-1a cells were prelabeled with 3 H-TdR by incubating 2610 5 cells/ml in essential medium with 0.5 mCi/ml 3 H-TdR at 378C for 16 h. The cells were washed three times and resuspended in RPMI-1640 medium and plated in 96-well plates (4610 4 /well, total volume 200 ml) with or without the test samples. One mg/ml of cycloheximide was added to increase the sensitivity of TNF (Kull and Cuatrecasas, 1981) . After incubation for 90 min or the indicated times, they were lysed by the addition of 50 ml of detergent buer (10 mM Tris-HCl pH 8.0 containing 5 mM EDTA and 2.5% Triton X-100) and incubated an additional 15 min at 48C. High-speed centrifugation was performed in an Eppendorf microcentrifuge at 12 000 g for 1 min. The radioactivity in the supernatant represents DNA release into cells due to DNA fragmentation. For the total count, cells were lysed by the addition of 50 ml of 0.5% sodium dodecyl sulfate. The percent DNA release was calculated as follows: % DNA fragmentation=(c.p.m. in test sample supernatant/total c.p.m.)6100. Each assay was done in triplicate and results are shown as the mean+s.e.
Respiration measurement
Oxygen consumption was measured with a Clark oxygen electrode (model 5300: Yellow Spring Instrument Co., Yellow Spring, OH, USA) as described (Granger and Lehninger, 1982) . Cells were permibilized with 0.0025% digitonin in respiration medium (0.25 M sucrose, 20 mM HEPES, pH 7.2, 2 mM KH 2 PO 4 and 1 mM EGTA), washed and then suspended at 3610 7 cells/ml in respiration medium. 0.8 ml of cell suspension was injected into the respiration chamber (378C) together with 1 mM ADP and then a mitochondrial substrate was added; 5 mM for malate/glutamate, 5 mM succinate or 1.0 mM ascorbate/ 0.2 mM TMPD to initiate State 3 respiration. Respiration was calculated as the rate of change in the O 2 concentration following the addition of a substrate, assuming an initial O 2 concentration as 217 mM/ml.
Assay for caspase 3-like protease
Caspase 3-like protease activity was measured with a modi®ed method by Enari et al. (1995) . Brie¯y, after cells (1610 6 ) were incubated with test samples, cytosolic extracts were prepared by repeated freezing and thawing in 300 ml extraction buer (Tris 12.5 mM, pH 7.0, DTT 1 mM, EDTA 0.125 mM, Glycerol 5%, PMSF 1 mM, 1 mg/ ml leupeptin, 1 mg/ml pepstatin, and 1 mg/ml aprotinin). Cell lysate was diluted with the buer (in mM) Tris 50, pH 7.0, DTT 1, EDTA 0.5, 20% glycerol, and incubated at 378C in the presence of 20 mM acetyl-Asp-Glu-Val-Aspaminomethylcoumarin, a caspase 3 substrate, and acetylTyr-Val-Ala-Asp-aminomethylcoumarin, a caspase 1 substrate. Fluorescent aminomethylcoumarin, a product formed, was measured at excitation 355 nM, emission 460 nM using Fluoroscan II (Labsystems, Helsinki, Finland).
Detection of cytochrome c release from mitochondria by Western blotting
After incubation of 1610 7 cells under certain conditions, ML-1a cells were harvested by centrifugation at 1800 g for 10 min. After washing with PBS, 20 ml of buer (sucrose 250 mM, Tris 12.5 mM, pH 7.0, DTT 1 mM, EDTA 0.125 mM, Glycerol 5%, PMSF 1 mM, leupeptin 1 mg/ml, pepstatin 1 mg/ml, and aprotinin 1 mg/ml) was added, and cells were disrupted by douncing 80 times in a 0.3 ml Kontes douncer with the B pestle (Kontes Glass Company). Protein gel electrophoresis was carried out using 20% polyacrylamide slab gels in the presence of 0.1% SDS. After electrophoresis, the proteins were transferred electrophoretically to nitrocellulose membrane. After inhibiting the nonspeci®c binding with dried milk, the membrane was incubated with anity-puri®ed anti-cytochrome c antibody 7H8.22C12 (Pharmingen, San Diego, CA, USA). The membrane was washed three times in TTBS, and then incubated with rabbit anti-mouse IgGhorseradish peroxidase conjugate. The membrane was then stained with an enhanced chemiluminescence system (Amersham Inc., UK) according to the supplier's instructions and exposed to X-ray ®lm. For Figure 8 and Table 3 , integrated density value of cytochrome c band was detected by using a densitometer. For Figure 8 , per cent of MPT induction was calculated as 0% at time 0 min and 100% at time 90 min.
Detection of the induction of MPT
Induction of MPT was evaluated by the decrease in mitochondrial membrane potential as described . Brie¯y, after stimulation with reagents, ML1a cells were incubated with DiOC 6 for 15 min at 378C, followed by analysis on a cyto¯uorometer (Facscalibar, excitation; 488 nm; emmission: 552 nm). For Figure 8 , per cent of MPT induction was calculated as 0% at time 0 min and 100% at time 90 min.
